Effective immediately, under the Statewide Treatment Protocols v.12.03, in Protocol 2.4 Behavioral Emergencies, Adult and Pediatric, the standing order authorization for paramedics to administer Haloperidol (Haldol) is by IM route only. The Department has been alerted that this medication is not approved by the U.S. Food and Drug Administration (FDA) for administration by IV route, and therefore that route of administration is not to be used at this time. See FDA
advisory specifically on this topic:
It is important that all paramedic-level ambulance services and their EMTs be aware that in accordance with FDA approval and manufacturer’s instructions, Haloperidol is to be administered by IM route only.
If you have any questions, please contact Patricia Reilly, Clinical Coordinator, at email@example.com or at 617-753-7318.
MA OEMS Advisory attached: